Department of Psychiatry and Psychotherapy CCM

Projects

• A placebo-Controlled Study Evaluating The Clinical Value of 100 mg Saredutant in Patients with MDD
• Actigraphically Monitored Placebo Controled Rivastigmine Treatment of Agitation in Alzheimer's Disease Patients
• Agomelatin in biological rhythm disturbances in mood disorders
• Asenapin and negative symptoms in schizophrenia
• Belohnungsabhängiges Verhalten bei normaler und dysfunktionaler zerebraler Funktion
• Berliner Bündnis gegen Depression
• Brain and platelet serotonin transporter in humas - [123I]-ADAM SPECT and serotonergic measurements in platelets
• Cell-specific synaptic plasticity of subicular pyramidal cells in temporal lobe epilepsy
• Cerebral correlates of negative symptoms and atypical antipsychotics (Aripiprazole)
• Comparison of algorithm-guided treatment with treatment as usual in inpatients with major depressive disorder
• Comparison of Quetiapine to Placebo in the Maintenance Treatment of Patients with Bipolar I Disorder
• Computational Neuroscience und multimodales Imaging bei Schizophrenie
• Dopaminergic mechanisms of cue-induced alkohol craving
• Duloxetine versus Duloxetine plus Non-Pharmacological Intervention in the Treatment of Depression
• Duloxetine versus Venlafaxine Extended Release in the Major Depressiive Disorder
• Dysfunction of glutamatergic neurotransmission in schizophrenia
• Efficacy and safety of escitalopram in the prevention of interferon-associated depression
• Efficacy and safety of levetiracetam in the inpatient treatment of alcohol withdrawal syndrome
• Efficacy and Safety of Quetiapine compared with Valproate in Bipolar Patients with Rapid Cycling
• Efficacy of Duloxetine in outpatients with major depressive disorder and pain
• EU - FINDER: prospektive Beobachtungsstudie zur Beschreibung der Lebensqualität von depressiven Patienten
• European Best Practices in Access, Quality and Appropriateness of Health Services for Immigrants in Europe
• European Huntington's Disease Initiative (EHDI): Riluzole in HD
• Evaluation of the Long-Term Course of Bipolar Disorder
• Experience of burden, mental state, and disorder-related knowledge of relatives of affectively disordered patients
• Früherkennungs- u. Therapieze
• Functions of Consciousness
• Gene expression profiles of bone marrow-derived cells in the brain after cerebral ischemia
• Genetic variability of treatment response and drug tolerability in bipolar
• Hepatitis-Psyche
• Immunology in Biopolar Disorder
• Levothyroxine as add-on therapy in bipolar depression
• Licarbazepine combined with lithium or valproate in acute mania
• Mechanisms of myeloid cell recruitment into the brain
• Modulation of the chemokine receptor, CCR2B, in hematopoietic cells as a therapeutic strategy in EAE
• Multimodal imaging of dopamine-glutamate interaction during reward processing
• Neue Pharmakotherapien bei ADHS im Erwachsenenalter
• Neural substrates of affective processing in depressed patients treated with escitalopram
• Neuroprotektive Effekte einer Lithium-Langzeitbehandlung bei bipolaren Patienten
• Panik-fMRI
• Photobiological basis of stimulated melatonin suppression
• PLACAR
• Placebokontrollierte multizentrische Doppelblindstudie mit Methylphenidat retard bei Erwachsenen-ADHS
• Predictors of therapeutic effects in antidepressant treatment
• PROMO- Best Practice in Promoting Mental Health in Socially Marginalized People in Europe
• Quality of live and reward processing in schizophrenia with atypical neuroleptics
• Regenerative potential of neural-induced mesenchymal stem cells after stroke
• Reward processing and atypical Antipsychotics
• Secondary Prevention of Schizophrenia. A randomized controlled trial Acronym: PREVENT
• Serotonintransporter und funkt. Aktivierung auf aversive Reize bei gesunden Kontrollpersonen und Zwangspatienten
• THC and cognition
• Thyroid Hormone and Mood Modulation in Bipolar Disorder: Neurobiological Mechanisms
• Validation in humans of genes involved in alcohol drinking, stress-induced alcohol drinking and relapse
• Wirksamkeit und Verträglichkeit von Memantine vs. Placebo als add-on-Behandlung bei schizophrenen Patienten

If the list does not contain any entry, the request was executed without results